The Immunotherapy Carve-Out: How Proposition 38 Hijacks Democracy for a Single Institute

The Facts: A Bond with a Built-In Beneficiary

On the November ballot, California voters will encounter Proposition 38, an $8.4 billion bond measure ostensibly designed to fund “cutting edge immunology research and cures” for heart disease, cancer, Alzheimer’s, and other major illnesses. The promise is grand: to vanquish disease through the power of immunotherapy. However, a CalMatters analysis reveals a stunning architectural flaw—or perhaps, a deliberate design feature—embedded within the proposition’s legal text.

Half of the bond’s funds, a staggering $4.2 billion, is allocated to a single, unnamed non-profit research institute. The language does not name this institute. Instead, it lays out pages of “oddly specific” eligibility criteria that, according to the analysis, appear tailor-made to exclude every entity in California except one: the California Institute for Immunology and Immunotherapy (CIII).

The Context: Specificity Pointing to a Singular Outcome

The criteria are remarkably precise. The qualifying institute must:

• Be a non-profit founded before 2025 focused primarily on immunology/immunotherapy.
• Be affiliated with a University of California campus with a medical center seeing over 3.5 million outpatient visits and 35,000 inpatient admissions annually. According to UC data, only UCLA currently meets this threshold.
• Occupy at least 200,000 square feet of research space. CIII press releases state it will occupy 360,000-500,000 sq ft on UCLA property.
• Have received at least $250 million in philanthropic support. CIII has reportedly received $250 million.
• Have a board that includes top officials from its affiliated UC campus. UCLA’s Chancellor, Julio Frenk, and Vice Chancellor for Research, Roger Wakimoto, are listed on CIII’s board.
• Have received two specific donations of at least $50 million each for a “rapid vaccine development program” and a “microbiome research program.” Billionaire Gary K. Michelson, a co-founder and chief backer of Prop 38, donated $50 million to CIII for programs with near-verbatim descriptions.

A UCLA spokesperson confirmed that among all its affiliated non-profits, only CIII could satisfy these stipulations. The proposition’s chief financial backer is Michelson himself, who, with his related non-profit, has donated over $8.2 million to the “Yes on 38” campaign. Another co-founder of CIII, Meyer Luskin, has donated at least $5 million.

The other half of the bond money would be distributed via competitive grants, but even this process is structured to maintain a close, privileged relationship with the chosen institute, which would “confer” on funding decisions and be offered collaboration on clinical trials.

Opinion: A Fundamental Assault on Democratic Norms and Fiscal Integrity

This is not simply poor policy; it is a profound corruption of the democratic process. Proposition 38 represents a cynical and sophisticated attempt to use the ballot initiative system—a tool of direct democracy—to enact a multi-billion-dollar earmark for a privately connected entity. It dresses a targeted financial windfall in the noble clothing of medical progress, hoping voters will not peer behind the curtain.

The Erosion of Transparency and Fair Competition

Professor Sarah Hill of Cal State Fullerton aptly labels the language “oddly specific”—a red flag for any voter. The deliberate omission of the institute’s name while crafting criteria that point unerringly to it is a masterclass in obfuscation. It creates a veneer of competitive openness where none exists. This is not an invitation to the best and brightest; it is a pre-written contract waiting for a single signature.

This approach utterly undermines the principles of fair competition and merit-based allocation of public resources. As Robert Kaplan, a former NIH associate director, argues, concentrating half the funding in one institute is unfair, given the breadth of talent across California’s research institutions. It presumes a monopoly on innovation and stifles the collaborative, diverse ecosystem that truly drives scientific discovery.

The campaign’s spokesperson, Claudia Briggs, defends the criteria as ensuring a “highly qualified” recipient prepared for “lifesaving research immediately.” But this defense rings hollow. If the goal was simply to fund a qualified, shovel-ready institute, why not name it and debate its merits openly? The specificity is not about quality assurance; it is about exclusionary precision. It is about guaranteeing an outcome while avoiding the accountability that comes with naming the beneficiary.

The Dangerous Precedent of Wealth Dictating Policy

The involvement of Gary K. Michelson as both the proposition’s bankroller and the co-founder of its apparent sole beneficiary creates an undeniable and toxic conflict of interest. It illustrates how immense private wealth can be leveraged to engineer public policy for private institutional gain. This is not philanthropy; it is a fiscal coup attempted through the ballot box.

The proposition’s defenders point to federal funding instability as a justification for state action. This is a valid concern. However, addressing a funding crisis by creating a rigged, non-competitive system is a cure worse than the disease. It sacrifices long-term institutional integrity for a short-term, politically-engineered cash infusion.

Furthermore, the financial burden is immense. The Legislative Analyst’s Office estimates Prop 38 will cost taxpayers $500 million annually for 25 years—a total of over $12 billion. To commit future generations to such debt for a process so fundamentally flawed is fiscally irresponsible and morally questionable.

A Call to Uphold Democratic Principles

As staunch supporters of the Constitution, the rule of law, and transparent governance, we must sound the alarm. Democracy withers not only through overt power grabs but through the gradual, legalistic erosion of its norms. Prop 38 is a textbook example of such erosion. It uses the letter of the law to violate its spirit: that public funds be allocated through transparent, equitable processes that serve the public interest, not a predetermined private interest.

The precedent is chilling. If this passes, what stops the next billionaire from drafting a proposition with “oddly specific” criteria for their own pet project? The ballot initiative becomes a pay-to-play tool for the ultra-wealthy, bypassing legislative scrutiny and public debate.

The promise of medical breakthroughs is powerful and emotional. We all yearn for cures. But we must never allow that hope to be weaponized to undermine the very systems designed to protect us from exploitation. The ends do not justify these means. Californians must see Prop 38 for what it is: a dangerously crafted measure that prioritizes a backroom deal over democratic fairness. To protect the integrity of our institutions and the responsible stewardship of public treasure, this proposition must be rejected. Our democracy, and the trust of the voters, depends on it.